FDA warns of steroids in vitamin B supplement

(AP)—The Food and Drug Administration is warning consumers to avoid a vitamin B dietary supplement from Healthy Life Chemistry by Purity First because it contains two potentially dangerous anabolic steroids.

The agency says the company's B-50 supplements tested positive for methasterone and dimethazine, two steroids sometimes used illegally by bodybuilders. Neither ingredient is listed on the product's labeling.

Federal regulators have received 29 reports of side effects connected with the product, including fatigue, muscle cramping and pain. Some of the cases have resulted in hospitalization, but there have been no reports of death or liver failure.

The product is manufactured by Mira Health Products Ltd. of Farmingdale, N.Y. and sold online and in stores. The FDA says the company has declined a government request to voluntarily recall the product.

5 /5 (2 votes)
add to favorites email to friend print save as pdf

Related Stories

FDA warns consumers of dangers of the stimulant DMAA

Apr 15, 2013

(HealthDay)—The U.S. Food and Drug Administration is attempting to halt distribution of dietary supplements that contain the stimulant dimethylamylamine (DMAA), following reports of illness and death associated ...

US cracks down on illegal diabetes remedies

Jul 23, 2013

(AP)—The Food and Drug Administration is cracking down on more than a dozen U.S. and foreign companies that market illegal treatments for diabetes, ranging from bogus dietary supplements to prescription ...

US warns of drugs in Reumofan dietary supplements

Aug 21, 2012

(AP) — The U.S. Food and Drug Administration is warning consumers not to use Reumofan dietary supplements, after receiving reports of bleeding, stroke and death among Americans taking the Mexico-manufactured pills.

Recommended for you

Determine patient preferences by means of conjoint analysis

8 hours ago

The Conjoint Analysis (CA) method is in principle suitable to find out which preferences patients have regarding treatment goals. However, to widely use it in health economic evaluations, some (primarily methodological) issues ...

FDA approves hard-to-abuse narcotic painkiller

Jul 25, 2014

(HealthDay)—A new formulation of a powerful narcotic painkiller that discourages potential abusers from snorting or injecting the drug has been approved by the U.S. Food and Drug Administration.

Race affects opioid selection for cancer pain

Jul 25, 2014

(HealthDay)—Racial disparities exist in the type of opioid prescribed for cancer pain, according to a study published online July 21 in the Journal of Clinical Oncology.

FDA approves tough-to-abuse formulation of oxycodone

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe ...

Tough-to-abuse formulation of oxycodone approved

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe pain when other ...

User comments